Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.78 |
| ▸ | RPA1 | P27694 | 1/20 | 0.55 |
| ▸ | XDH | P47989 | 1/20 | 0.52 |
| ▸ | LDHA | P00338 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | GPR35 | Q9HC97 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.48 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13113123 | 0.84 | IDO1 (0.65) | IDO1RPA1XDHLDHAMEN1 | |
| SCHEMBL5607916 | 0.83 | IDO1 (0.68) | IDO1RPA1XDHLDHAMEN1 | |
| SCHEMBL13113385 | 0.80 | IDO1 (0.70) | IDO1RPA1XDHLDHAMEN1 | |
| SCHEMBL5607418 | 0.80 | IDO1 (0.59) | IDO1RPA1XDHLDHAMEN1 | |
| SCHEMBL18262946 | 0.79 | IDO1 (0.54) | IDO1LDHAMEN1KMT2AALDH1A1 | |
| SCHEMBL25256300 | 0.77 | IDO1 (0.66) | IDO1RPA1XDHLDHAMEN1 | |
| SCHEMBL19554299 | 0.77 | IDO1 (1.00) | IDO1RPA1XDHLDHAMEN1 | |
| SCHEMBL30042814 | 0.77 | XDH (0.79) | IDO1RPA1XDHLDHAMEN1 | |
| SCHEMBL23529297 | 0.77 | XDH (0.79) | IDO1RPA1XDHLDHAMEN1 | |
| SCHEMBL14556369 | 0.76 | IDO1 (0.58) | IDO1RPA1LDHAGPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110184187-A1 | PROCESS FOR THE PREPARATION OF TETRAZOLE DERIVATIVES FROM ORGANO BORON AND ORGANO ALUMINIUM AZIDES | SEDELMEIER GOTTFRIED | 2011-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110184187-A1 | PROCESS FOR THE PREPARATION OF TETRAZOLE DERIVATIVES FROM ORGANO BORON AND ORGANO ALUMINIUM AZIDES | ABL1, TBCA, TBC1D5 | IDO1 2179/4885RPA1 3393/4885XDH 1797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.